OVERVIEW:
The Edelman Laboratory uses elements of continuum mechanics, digital signal processing, molecular biology and polymeric controlled release technology to examine the cellular and molecular mechanisms that transform stable coronary-artery disease to unstable coronary syndromes. Tissue-generated cells, for example, deliver growth factors and growth inhibitors for the study and potential treatment of accelerated arterial disease following angioplasty and bypass surgery. The laboratory holds patents for drug-delivery devices, tissue-engineered implants, and new drug formulations.
- Selection of recent publications
Keywords:
Drug delivery, controlled release, growth factors, stent, tissue engineering
Key References:
- Drug Delivery Group
- Arterial Imaging Group
- Vascular Biology Group
- Implanted Devices Group
- Tissue Engineering Group
- Angiogenesis Group
- Intensive Care Group
Natalie Artzi
Mercedes Balcells
Shmulik Hess
Michael Jonas
Kumaran Kolandaivelu
Heiko Methe
Li Yuan Mi
Janne Ostvang
Shai Schubert
Rami Tzafriri
Brett Zani
Maria del Carmen Alegret
Irina Alexander
Aaron Baker
Brinda Balakrishnan
David Elihu
Tarek Elshazly
Michael Feldstein
Chen-Wen Huang
Kha Le
Andrew Levin
Hector Mobine
Alisa Morss
Sylaja Murikipudi
Maria Tarragona
Neda Vukmirovic
Peter Wu
Jacqueline Brazin
Youngsun Cho
Stephanie Flavin
Leighanne Gallington
Mavis Li
Joseph Wallins
Abraham Wei
Leslie Arnold
Adam Groothuis
Gilandokht Hashemi
Michele Miele
Mamoru Nanasato
Phil Seifert
Laurie May
Yvette Miller
Gee Wong
77 Massachusetts Avenue, Building E25-438, Cambridge, MA 02139. USA.
Tel: 617-253-1569. Fax: 617-253-2514. E-mail: ere@mit.edu.
Copyright (C) 1998-2005 Massachusetts Institute of Technology. All rights reserved.
